DEGARELIX

DEGARELIX was reported 5333 times

DEGARELIX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE PLAQUE 5 0.2174
1 TISSUE RUPTURE 6 0.1200
2 HORMONE-DEPENDENT PROSTATE CANCER 8 0.1143
3 IDIOPATHIC PANCREATITIS 4 0.1111
4 HYPOPARATHYROIDISM SECONDARY 7 0.0603
5 NEUROENDOCRINE CARCINOMA OF PROSTATE 4 0.0588
6 HOMOSEXUALITY 3 0.0492
7 PROSTATIC SPECIFIC ANTIGEN DECREASED 18 0.0476
8 APPARENT MINERALOCORTICOID EXCESS 2 0.0345
9 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 35 0.0337
10 HYPERADRENALISM 4 0.0328
11 MUCOCUTANEOUS DISORDER 5 0.0314
12 URETHRAL OBSTRUCTION 9 0.0222
13 BLOOD TESTOSTERONE ABNORMAL 24 0.0217
14 CEREBRAL AMYLOID ANGIOPATHY 7 0.0212
15 GASTROINTESTINAL ANASTOMOTIC STENOSIS 2 0.0211
16 SPINAL CORD INFARCTION 9 0.0204
17 HORMONE-REFRACTORY PROSTATE CANCER 24 0.0202
18 INJECTION SITE CELLULITIS 37 0.0199
19 COLD-STIMULUS HEADACHE 6 0.0188
20 PROSTATE CANCER METASTATIC 62 0.0185
21 NECROTISING RETINITIS 11 0.0172
22 RESPIRATORY MONILIASIS 4 0.0149
23 AUTONOMIC DYSREFLEXIA 2 0.0123
24 BLADDER CYST 2 0.0123
25 PROSTATIC SPECIFIC ANTIGEN INCREASED 166 0.0120
26 MENINGORRHAGIA 3 0.0120
27 BLOOD TESTOSTERONE INCREASED 25 0.0116
28 POSTRENAL FAILURE 5 0.0114
29 MALE SEXUAL DYSFUNCTION 6 0.0100
30 VENTRICULAR FAILURE 3 0.0096
31 PROSTATIC HAEMORRHAGE 3 0.0094
32 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 6 0.0093
33 CARDIAC PERFORATION 2 0.0087
34 INJECTION SITE ABSCESS 19 0.0076
35 URETEROLITHIASIS 8 0.0076
36 RETROPERITONEAL LYMPHADENOPATHY 4 0.0076
37 SCROTAL PAIN 4 0.0074
38 INJECTION SITE INDURATION 93 0.0072
39 BONE SCAN ABNORMAL 3 0.0071
40 ERYTHROPENIA 2 0.0066
41 PROSTATE CANCER RECURRENT 4 0.0065
42 RESPIRATORY TRACT INFLAMMATION 3 0.0064
43 PENILE SIZE REDUCED 6 0.0063
44 EROSIVE DUODENITIS 5 0.0063
45 ABDOMINAL WALL ABSCESS 4 0.0062
46 TUMOUR INVASION 3 0.0062
47 ADMINISTRATION SITE SWELLING 2 0.0062
48 HYPERCREATINAEMIA 2 0.0060
49 METASTASES TO BONE MARROW 3 0.0060
50 BLADDER OBSTRUCTION 3 0.0058
51 BONE NEOPLASM 6 0.0056
52 VASOGENIC CEREBRAL OEDEMA 4 0.0056
53 INJECTION SITE INFLAMMATION 26 0.0052
54 INJECTION SITE NODULE 53 0.0048
55 TESTICULAR SWELLING 6 0.0047
56 URINARY TRACT OBSTRUCTION 11 0.0046
57 FEELINGS OF WORTHLESSNESS 6 0.0046
58 TESTICULAR ATROPHY 4 0.0046
59 EXTRADURAL HAEMATOMA 6 0.0045
60 HOT FLUSH 329 0.0044
61 VASCULAR PURPURA 6 0.0043
62 METASTASES TO BONE 69 0.0042
63 METASTASES TO SPINE 14 0.0042
64 TRAUMATIC FRACTURE 3 0.0041
65 INJECTION SITE OEDEMA 7 0.0041
66 TESTICULAR DISORDER 4 0.0040
67 INDURATION 7 0.0039
68 KELOID SCAR 2 0.0039
69 BLOOD ALBUMIN ABNORMAL 2 0.0038
70 ACUTE INTERSTITIAL PNEUMONITIS 2 0.0038
71 FAECAL VOMITING 2 0.0038
72 URETERIC STENOSIS 3 0.0037
73 LEFT ATRIAL ENLARGEMENT 2 0.0037
74 GASTROENTERITIS SALMONELLA 3 0.0036
75 HELICOBACTER TEST POSITIVE 2 0.0036
76 ENCEPHALOMALACIA 2 0.0036
77 INTRACRANIAL HAEMATOMA 2 0.0036
78 INJECTION SITE MASS 131 0.0035
79 INJECTION SITE INFECTION 11 0.0033
80 ONYCHOLYSIS 5 0.0032
81 WRONG SCHEDULE 3 0.0031
82 SPINAL COLUMN INJURY 7 0.0031
83 SEDATION COMPLICATION 8 0.0031
84 CANCER PAIN 8 0.0031
85 HEAT ILLNESS 2 0.0030
86 INFECTIOUS PERITONITIS 2 0.0029
87 INJECTION SITE DISCOMFORT 31 0.0029
88 CENTRAL SEROUS CHORIORETINOPATHY 2 0.0029
89 WAIST CIRCUMFERENCE INCREASED 3 0.0029
90 TESTICULAR PAIN 9 0.0028
91 INJECTION SITE SWELLING 212 0.0028
92 DERMATOMYOSITIS 7 0.0028
93 LIP EROSION 2 0.0027
94 ACUTE ABDOMEN 4 0.0027
95 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3 0.0027
96 METASTASES TO LYMPH NODES 18 0.0027
97 SECONDARY ADRENOCORTICAL INSUFFICIENCY 4 0.0026
98 RADIOTHERAPY 5 0.0026
99 UROSEPSIS 24 0.0026
100 ABDOMINAL SYMPTOM 2 0.0025
101 INJECTION SITE WARMTH 51 0.0025
102 PERIPHERAL SENSORIMOTOR NEUROPATHY 3 0.0024
103 PRODUCT STORAGE ERROR 209 0.0024
104 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 4 0.0024
105 OSTEITIS 6 0.0024
106 INJECTION SITE ERYTHEMA 293 0.0024
107 PRODUCT LEAKAGE 13 0.0023
108 SPINAL CORD COMPRESSION 9 0.0023
109 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
110 PEMPHIGOID 17 0.0023
111 ABDOMINAL MASS 6 0.0022
112 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
113 ABDOMINAL RIGIDITY 6 0.0022
114 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 37 0.0022
115 LUNG CONSOLIDATION 6 0.0021
116 OSTEONECROSIS OF JAW 53 0.0021
117 BLADDER TRANSITIONAL CELL CARCINOMA 3 0.0021
118 URINE FLOW DECREASED 5 0.0021
119 RADIUS FRACTURE 5 0.0021
120 LEFT VENTRICULAR FAILURE 7 0.0020
121 HYPOCALCAEMIA 38 0.0020
122 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
123 ACQUIRED HAEMOPHILIA 2 0.0020
124 DROWNING 2 0.0020
125 FEMORAL NECK FRACTURE 10 0.0019
126 BLOOD TESTOSTERONE DECREASED 13 0.0019
127 URINARY BLADDER HAEMORRHAGE 4 0.0019
128 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
129 ODYNOPHAGIA 11 0.0018
130 MONOPLEGIA 8 0.0018
131 LISTLESS 6 0.0018
132 INJECTION RELATED REACTION 3 0.0018
133 ABDOMINAL TENDERNESS 9 0.0018
134 PRODUCT LOT NUMBER ISSUE 4 0.0018
135 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 33 0.0018
136 POST PROCEDURAL HAEMATOMA 3 0.0018
137 APLASIA PURE RED CELL 6 0.0017
138 ADMINISTRATION SITE PAIN 2 0.0017
139 HEPATITIS FULMINANT 5 0.0017
140 PRODUCT PREPARATION ISSUE 11 0.0017
141 BONE LESION 6 0.0017
142 MUSCLE FATIGUE 7 0.0017
143 AMPUTATION 2 0.0016
144 HYDRONEPHROSIS 12 0.0016
145 LEFT ATRIAL DILATATION 2 0.0016
146 OSTEOPOROTIC FRACTURE 3 0.0016
147 NOCTURIA 19 0.0016
148 HYPOREFLEXIA 3 0.0016
149 LIPOMA 4 0.0015
150 ABDOMINAL WALL HAEMATOMA 3 0.0015
151 SYRINGE ISSUE 26 0.0015
152 METASTASES TO LIVER 26 0.0015
153 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
154 INJECTION SITE NECROSIS 3 0.0015
155 DISEASE PROGRESSION 174 0.0015
156 CALCULUS BLADDER 2 0.0015
157 CARDIOVERSION 2 0.0014
158 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
159 BLADDER DISORDER 14 0.0014
160 INJECTION SITE SCAR 4 0.0014
161 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
162 INTERCEPTED PRODUCT STORAGE ERROR 5 0.0014
163 METASTASIS 10 0.0014
164 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
165 INTERSTITIAL LUNG DISEASE 66 0.0014
166 IMMUNOSUPPRESSION 12 0.0014
167 ISCHAEMIC STROKE 24 0.0013
168 CHOLANGIOCARCINOMA 2 0.0013
169 PROSTATE CANCER 106 0.0013
170 INJECTION SITE REACTION 90 0.0013
171 COMPRESSION FRACTURE 7 0.0013
172 LOCALISED OEDEMA 6 0.0013
173 INJECTION SITE HYPERSENSITIVITY 4 0.0013
174 FUNGAEMIA 2 0.0013
175 URINARY HESITATION 3 0.0013
176 GROIN PAIN 11 0.0013
177 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
178 RETINAL DETACHMENT 11 0.0012
179 INJECTION SITE PAIN 367 0.0012
180 HAEMORRHAGE URINARY TRACT 3 0.0012
181 FOOD AVERSION 2 0.0012
182 URINARY RETENTION 39 0.0012
183 PHYSICAL DECONDITIONING 3 0.0012
184 INTERCEPTED PRODUCT PREPARATION ERROR 14 0.0011
185 LOSS OF LIBIDO 10 0.0011
186 BONE PAIN 65 0.0011
187 DERMATITIS BULLOUS 8 0.0011
188 MUSCLE ATROPHY 14 0.0011
189 ERECTILE DYSFUNCTION 28 0.0011
190 POLYNEUROPATHY 13 0.0011
191 PERSONALITY CHANGE 10 0.0011
192 ANAL HAEMORRHAGE 3 0.0011
193 TONGUE OEDEMA 4 0.0010
194 TERMINAL STATE 7 0.0010
195 RESTLESS LEGS SYNDROME 19 0.0010
196 HYPERTONIC BLADDER 3 0.0010
197 CHILLS 121 0.0010
198 CONCOMITANT DISEASE PROGRESSION 2 0.0010
199 PRODUCT PREPARATION ERROR 21 0.0010
200 INJECTION SITE IRRITATION 13 0.0010
201 BODY TEMPERATURE DECREASED 10 0.0010
202 HYPERAEMIA 2 0.0010
203 GENE MUTATION 2 0.0010
204 URINE ANALYSIS ABNORMAL 3 0.0010
205 BLOOD URINE PRESENT 19 0.0010
206 TOXIC SKIN ERUPTION 10 0.0010
207 DUODENAL ULCER 7 0.0010
208 RECTAL CANCER 3 0.0010
209 CACHEXIA 5 0.0010
210 AGRANULOCYTOSIS 18 0.0010
211 RASH PUSTULAR 7 0.0010
212 FLANK PAIN 9 0.0010
213 MALIGNANT NEOPLASM PROGRESSION 98 0.0010
214 FOREIGN BODY IN THROAT 3 0.0010
215 NON-CARDIAC CHEST PAIN 3 0.0009
216 SUDDEN DEATH 10 0.0009
217 RASH MACULO-PAPULAR 21 0.0009
218 FEBRILE BONE MARROW APLASIA 4 0.0009
219 OCCUPATIONAL EXPOSURE TO PRODUCT 6 0.0009
220 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 24 0.0009
221 HYPERTHERMIA 7 0.0009
222 HAEMORRHAGIC ANAEMIA 4 0.0009
223 ABDOMINAL ABSCESS 4 0.0009
224 DYSURIA 33 0.0009
225 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
226 LICHENOID KERATOSIS 2 0.0009
227 EYELID DISORDER 2 0.0009
228 APHTHOUS STOMATITIS 2 0.0009
229 HYPOKALAEMIA 40 0.0009
230 LARGE INTESTINE POLYP 6 0.0009
231 FEELING COLD 24 0.0009
232 HYPOMAGNESAEMIA 12 0.0009
233 AORTIC STENOSIS 3 0.0009
234 CEREBRAL INFARCTION 21 0.0009
235 HEPATIC FUNCTION ABNORMAL 32 0.0009
236 THROMBOPHLEBITIS 3 0.0009
237 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
238 METASTASES TO CENTRAL NERVOUS SYSTEM 11 0.0009
239 EMBOLIC STROKE 3 0.0009
240 SPINAL COMPRESSION FRACTURE 7 0.0008
241 SKIN ABRASION 4 0.0008
242 ATAXIA 10 0.0008
243 FAECAL INCONTINENCE 4 0.0008
244 HYPERKALAEMIA 29 0.0008
245 INJECTION SITE RASH 25 0.0008
246 FEELING DRUNK 6 0.0008
247 BLOOD CALCIUM INCREASED 7 0.0008
248 BRAIN INJURY 8 0.0008
249 ERYSIPELAS 4 0.0008
250 ENDODONTIC PROCEDURE 2 0.0008
251 HAEMATURIA 27 0.0008
252 MICTURITION URGENCY 9 0.0008
253 MASS 11 0.0008
254 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
255 CLAVICLE FRACTURE 3 0.0008
256 CORONAVIRUS INFECTION 5 0.0008
257 CELLULITIS 38 0.0008
258 DYSSTASIA 22 0.0008
259 AZOTAEMIA 3 0.0008
260 SKIN MASS 5 0.0007
261 POLLAKIURIA 31 0.0007
262 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
263 CARDIAC FAILURE 59 0.0007
264 SMALL INTESTINAL OBSTRUCTION 9 0.0007
265 GOUT 13 0.0007
266 HAEMORRHOIDS 14 0.0007
267 BLOOD CALCIUM DECREASED 8 0.0007
268 INTESTINAL STENOSIS 3 0.0007
269 MUSCULOSKELETAL CHEST PAIN 11 0.0007
270 HYPERPYREXIA 3 0.0007
271 FACIAL PARALYSIS 6 0.0007
272 METASTATIC NEOPLASM 3 0.0007
273 EXERCISE TOLERANCE DECREASED 4 0.0007
274 PYELONEPHRITIS 6 0.0007
275 OCULAR ICTERUS 3 0.0007
276 DYSPNOEA AT REST 2 0.0007
277 PLATELET COUNT INCREASED 9 0.0007
278 BONE CANCER 3 0.0007
279 BLOOD PARATHYROID HORMONE INCREASED 2 0.0007
280 BODY TEMPERATURE INCREASED 14 0.0007
281 DIVERTICULUM INTESTINAL 3 0.0007
282 APATHY 10 0.0007
283 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
284 COLD SWEAT 12 0.0007
285 ADVERSE REACTION 9 0.0007
286 STEVENS-JOHNSON SYNDROME 15 0.0007
287 HAEMATEMESIS 17 0.0007
288 ANAL INCONTINENCE 6 0.0007
289 HALLUCINATION, VISUAL 14 0.0007
290 INJECTION SITE VESICLES 4 0.0007
291 ANAPHYLACTIC SHOCK 17 0.0007
292 GENERAL PHYSICAL HEALTH DETERIORATION 76 0.0007
293 RESPIRATORY DEPRESSION 8 0.0007
294 DYSAESTHESIA 2 0.0007
295 CHEST X-RAY ABNORMAL 2 0.0007
296 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
297 COORDINATION ABNORMAL 9 0.0006
298 HYPERHIDROSIS 83 0.0006
299 INFUSION SITE EXTRAVASATION 4 0.0006
300 YELLOW SKIN 3 0.0006
301 SYNCOPE 64 0.0006
302 BLOOD CREATININE DECREASED 2 0.0006
303 GASTROINTESTINAL INFLAMMATION 5 0.0006
304 INVESTIGATION 2 0.0006
305 RENAL CYST 5 0.0006
306 HYPERTENSIVE CRISIS 7 0.0006
307 HUMERUS FRACTURE 3 0.0006
308 INTENTIONAL DRUG MISUSE 13 0.0006
309 HYPERCHOLESTEROLAEMIA 6 0.0006
310 INCOHERENT 4 0.0006
311 MOUTH ULCERATION 13 0.0006
312 HEPATIC NEOPLASM 2 0.0006
313 BREAST ENLARGEMENT 2 0.0006
314 STAPHYLOCOCCAL SEPSIS 3 0.0006
315 WALKING AID USER 4 0.0006
316 METASTASES TO LUNG 7 0.0006
317 ORGANISING PNEUMONIA 3 0.0006
318 RHABDOMYOLYSIS 25 0.0006
319 ASTHENIA 224 0.0006
320 CEREBRAL HAEMATOMA 2 0.0006
321 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
322 PRODUCT ADMINISTRATION ERROR 12 0.0006
323 COLITIS ISCHAEMIC 4 0.0006
324 CORONARY ARTERIAL STENT INSERTION 3 0.0006
325 TASTE DISORDER 12 0.0006
326 ARRHYTHMIA 28 0.0006
327 PATHOLOGICAL FRACTURE 3 0.0006
328 DYSLIPIDAEMIA 3 0.0006
329 NIGHT SWEATS 19 0.0006
330 TOOTH ABSCESS 6 0.0006
331 LIVER DISORDER 26 0.0006
332 PHLEBITIS 3 0.0006
333 CERVICAL VERTEBRAL FRACTURE 2 0.0006
334 HYPOPNOEA 2 0.0006
335 CAROTID ARTERY STENOSIS 2 0.0006
336 URINE OUTPUT DECREASED 5 0.0006
337 CATATONIA 3 0.0006
338 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6 0.0006
339 SERUM FERRITIN INCREASED 3 0.0006
340 JOINT DISLOCATION 6 0.0006
341 JAUNDICE CHOLESTATIC 2 0.0006
342 PULMONARY TOXICITY 4 0.0006
343 NYSTAGMUS 3 0.0006
344 LYMPHADENOPATHY 20 0.0006
345 FIBRIN D DIMER INCREASED 2 0.0006
346 FACIAL PAIN 5 0.0006
347 PRODUCT SIZE ISSUE 3 0.0006
348 INTESTINAL RESECTION 3 0.0006
349 FEBRILE NEUTROPENIA 37 0.0006
350 GINGIVITIS 3 0.0006
351 DECREASED ACTIVITY 6 0.0006
352 BRAIN OEDEMA 7 0.0006
353 VISUAL FIELD DEFECT 4 0.0006
354 PELVIC PAIN 10 0.0005
355 CAROTID ARTERY OCCLUSION 2 0.0005
356 BACK PAIN 127 0.0005
357 VENTRICULAR TACHYCARDIA 9 0.0005
358 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
359 DECREASED APPETITE 126 0.0005
360 GASTRIC ULCER HAEMORRHAGE 3 0.0005
361 HYPOPHOSPHATAEMIA 4 0.0005
362 LETHARGY 31 0.0005
363 GAIT INABILITY 18 0.0005
364 ALANINE AMINOTRANSFERASE INCREASED 33 0.0005
365 PANCREATITIS ACUTE 12 0.0005
366 BEDRIDDEN 7 0.0005
367 HEPATIC NECROSIS 2 0.0005
368 FATIGUE 412 0.0005
369 AUTOIMMUNE THYROIDITIS 2 0.0005
370 CATHETER SITE INFECTION 2 0.0005
371 CHEMOTHERAPY 2 0.0005
372 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
373 FACE INJURY 2 0.0005
374 HEPATOCELLULAR CARCINOMA 4 0.0005
375 AORTIC ANEURYSM 4 0.0005
376 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
377 INFLAMMATION 27 0.0005
378 MUSCULOSKELETAL DISCOMFORT 9 0.0005
379 QUALITY OF LIFE DECREASED 7 0.0005
380 CORONARY ARTERY BYPASS 3 0.0005
381 SPINAL PAIN 6 0.0005
382 CORONARY ARTERY OCCLUSION 7 0.0005
383 TORSADE DE POINTES 4 0.0005
384 DRUG ERUPTION 9 0.0005
385 ABDOMINAL DISTENSION 53 0.0005
386 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
387 HAEMATOCRIT DECREASED 10 0.0005
388 BLOOD PRESSURE ABNORMAL 10 0.0005
389 ANAEMIA 95 0.0005
390 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
391 SENSORY LOSS 4 0.0005
392 FUNGAL SKIN INFECTION 2 0.0005
393 PYREXIA 171 0.0005
394 SHOCK HAEMORRHAGIC 4 0.0005
395 ASPHYXIA 4 0.0005
396 INITIAL INSOMNIA 5 0.0005
397 OSTEONECROSIS 16 0.0005
398 MOBILITY DECREASED 35 0.0005
399 FALL 162 0.0005
400 HYPERURICAEMIA 2 0.0005
401 ANAPHYLACTOID REACTION 2 0.0005
402 INFLUENZA LIKE ILLNESS 40 0.0005
403 ABASIA 12 0.0005
404 GYNAECOMASTIA 15 0.0005
405 AORTIC DISSECTION 2 0.0005
406 ACUTE CORONARY SYNDROME 4 0.0005
407 INJECTION SITE HAEMATOMA 7 0.0005
408 SECOND PRIMARY MALIGNANCY 4 0.0005
409 DISORIENTATION 19 0.0005
410 TRANSFUSION 5 0.0005
411 INCORRECT ROUTE OF DRUG ADMINISTRATION 17 0.0005
412 FACE OEDEMA 8 0.0005
413 INCONTINENCE 5 0.0005
414 ABDOMINAL PAIN 110 0.0005
415 URINARY INCONTINENCE 14 0.0005
416 HEPATIC CYTOLYSIS 6 0.0005
417 BREAST PAIN 5 0.0005
418 LOSS OF CONSCIOUSNESS 60 0.0005
419 HAEMOGLOBIN ABNORMAL 3 0.0005
420 BLOOD POTASSIUM DECREASED 14 0.0005
421 UNRESPONSIVE TO STIMULI 12 0.0005
422 DEHYDRATION 62 0.0005
423 INJECTION SITE PRURITUS 31 0.0005
424 HEPATITIS ACUTE 3 0.0005
425 ANGINA UNSTABLE 3 0.0005
426 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
427 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
428 NODULE 6 0.0005
429 IMMOBILE 2 0.0005
430 PERIPHERAL SWELLING 70 0.0005
431 ANGINA PECTORIS 13 0.0005
432 ATRIAL FIBRILLATION 44 0.0005
433 BLOOD PRESSURE DECREASED 30 0.0005
434 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
435 RESPIRATORY RATE INCREASED 4 0.0005
436 CARDIAC FAILURE ACUTE 3 0.0004
437 MUSCULAR WEAKNESS 51 0.0004
438 ILEUS PARALYTIC 2 0.0004
439 BRAIN NEOPLASM MALIGNANT 2 0.0004
440 DIABETES MELLITUS 34 0.0004
441 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
442 ACUTE KIDNEY INJURY 68 0.0004
443 PRODUCT LABEL ISSUE 3 0.0004
444 PALLOR 12 0.0004
445 BONE DISORDER 8 0.0004
446 HAEMOGLOBIN INCREASED 2 0.0004
447 INFARCTION 3 0.0004
448 NEPHROTIC SYNDROME 3 0.0004
449 LYMPHOEDEMA 3 0.0004
450 NERVE COMPRESSION 4 0.0004
451 LARGE INTESTINE PERFORATION 3 0.0004
452 CONSTIPATION 94 0.0004
453 CEREBROVASCULAR ACCIDENT 73 0.0004
454 ERYTHEMA MULTIFORME 4 0.0004
455 HAEMOGLOBIN DECREASED 44 0.0004
456 HEART RATE DECREASED 15 0.0004
457 DEVICE OCCLUSION 6 0.0004
458 PULMONARY EMBOLISM 40 0.0004
459 CARDIAC TAMPONADE 2 0.0004
460 PRODUCT SUPPLY ISSUE 3 0.0004
461 LIMB DISCOMFORT 13 0.0004
462 MUSCULOSKELETAL PAIN 22 0.0004
463 RED BLOOD CELL COUNT DECREASED 12 0.0004
464 INCREASED APPETITE 8 0.0004
465 HYPOVOLAEMIC SHOCK 2 0.0004
466 CHOLESTASIS 8 0.0004
467 URINARY TRACT INFECTION 71 0.0004
468 APHAGIA 2 0.0004
469 CANDIDA INFECTION 7 0.0004
470 ADRENAL INSUFFICIENCY 5 0.0004
471 VERTIGO 25 0.0004
472 CYSTITIS 13 0.0004
473 RENAL TUBULAR NECROSIS 4 0.0004
474 ACUTE MYOCARDIAL INFARCTION 12 0.0004
475 HOSPICE CARE 4 0.0004
476 HIP FRACTURE 13 0.0004
477 PNEUMONITIS 11 0.0004
478 DUODENAL ULCER PERFORATION 3 0.0004
479 COLON CANCER 6 0.0004
480 THROMBOCYTOPENIA 45 0.0004
481 OEDEMA PERIPHERAL 49 0.0004
482 TOOTH EXTRACTION 5 0.0004
483 UPPER LIMB FRACTURE 8 0.0004
484 HYPERNATRAEMIA 2 0.0004
485 RENAL FAILURE ACUTE 17 0.0004
486 INJECTION SITE DISCOLOURATION 5 0.0004
487 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
488 PRODUCT USE ISSUE 75 0.0004
489 HEPATIC FAILURE 12 0.0004
490 CORONARY ARTERY STENOSIS 2 0.0004
491 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
492 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
493 STAPHYLOCOCCAL INFECTION 13 0.0004
494 DEMENTIA 11 0.0004
495 DISSOCIATION 3 0.0004
496 HYPOPHAGIA 10 0.0004
497 EXPIRED PRODUCT ADMINISTERED 13 0.0004
498 CONFUSIONAL STATE 63 0.0004
499 RIB FRACTURE 8 0.0004
500 CEREBRAL ISCHAEMIA 2 0.0004
501 MYALGIA 66 0.0004
502 GASTROENTERITIS VIRAL 7 0.0004
503 FEMUR FRACTURE 12 0.0004
504 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
505 HYPERBILIRUBINAEMIA 4 0.0004
506 FAILURE TO THRIVE 2 0.0004
507 HYPERGLYCAEMIA 14 0.0004
508 HYPERSOMNIA 11 0.0004
509 PRODUCT USE COMPLAINT 6 0.0004
510 GASTRITIS 10 0.0004
511 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
512 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
513 HALLUCINATION, AUDITORY 6 0.0004
514 PANCYTOPENIA 21 0.0004
515 RETCHING 8 0.0004
516 BODY HEIGHT DECREASED 4 0.0004
517 MENTAL IMPAIRMENT 9 0.0004
518 ANAL ABSCESS 2 0.0004
519 BALANCE DISORDER 32 0.0004
520 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
521 HYPOTENSION 74 0.0004
522 NEUROPATHY PERIPHERAL 35 0.0004
523 NEUTROPENIA 50 0.0004
524 INJECTION SITE URTICARIA 9 0.0004
525 POLYURIA 3 0.0004
526 DRUG INTERACTION 58 0.0004
527 APHASIA 11 0.0004
528 PERIPHERAL COLDNESS 5 0.0004
529 HERNIA 7 0.0004
530 HEMIPLEGIA 3 0.0004
531 RENAL IMPAIRMENT 30 0.0004
532 ACUTE PULMONARY OEDEMA 2 0.0004
533 AMNESIA 23 0.0004
534 MITRAL VALVE INCOMPETENCE 4 0.0004
535 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
536 CHOLECYSTITIS ACUTE 2 0.0004
537 HEPATOCELLULAR INJURY 5 0.0004
538 SWELLING 33 0.0004
539 GRANULOCYTOPENIA 2 0.0004
540 VITAMIN D DECREASED 3 0.0004
541 PRESCRIBED UNDERDOSE 7 0.0004
542 MYOCARDIAL INFARCTION 61 0.0003
543 SEPSIS 39 0.0003
544 PARALYSIS 5 0.0003
545 WEIGHT INCREASED 78 0.0003
546 NEOPLASM 4 0.0003
547 SHOCK 8 0.0003
548 BLOOD MAGNESIUM DECREASED 3 0.0003
549 MYOPATHY 3 0.0003
550 MUSCLE TWITCHING 8 0.0003
551 CARDIAC MURMUR 3 0.0003
552 SKIN SWELLING 3 0.0003
553 DYSPNOEA EXERTIONAL 13 0.0003
554 SEPTIC SHOCK 15 0.0003
555 ELECTROLYTE IMBALANCE 4 0.0003
556 MUCOSAL INFLAMMATION 9 0.0003
557 RASH MACULAR 12 0.0003
558 UNDERDOSE 25 0.0003
559 EOSINOPHILIA 6 0.0003
560 HYPOAESTHESIA 51 0.0003
561 CATARACT OPERATION 2 0.0003
562 HYPERLIPIDAEMIA 4 0.0003
563 BLOOD BILIRUBIN INCREASED 9 0.0003
564 INCORRECT DOSE ADMINISTERED 76 0.0003
565 OSTEOMYELITIS 6 0.0003
566 PRESYNCOPE 8 0.0003
567 NEURALGIA 8 0.0003
568 INSURANCE ISSUE 5 0.0003
569 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
570 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
571 DEVICE RELATED INFECTION 5 0.0003
572 INJECTION SITE EXTRAVASATION 4 0.0003
573 CHEST PAIN 60 0.0003
574 ILEUS 4 0.0003
575 AGEUSIA 8 0.0003
576 PNEUMONIA ASPIRATION 8 0.0003
577 ARTHRALGIA 133 0.0003
578 NEUTROPHIL COUNT DECREASED 13 0.0003
579 ARTERIOSCLEROSIS 3 0.0003
580 DRUG-INDUCED LIVER INJURY 10 0.0003
581 FRACTURE 6 0.0003
582 SPINAL DISORDER 3 0.0003
583 ENTERITIS 2 0.0003
584 WEIGHT DECREASED 87 0.0003
585 MOVEMENT DISORDER 10 0.0003
586 DIZZINESS 154 0.0003
587 BLOOD POTASSIUM INCREASED 5 0.0003
588 CEREBRAL HAEMORRHAGE 11 0.0003
589 CARDIAC ARREST 25 0.0003
590 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
591 EMPHYSEMA 3 0.0003
592 ERYTHEMA 61 0.0003
593 FEEDING DISORDER 6 0.0003
594 PLEURAL EFFUSION 18 0.0003
595 BLOOD PRESSURE INCREASED 45 0.0003
596 TACHYPNOEA 4 0.0003
597 PRODUCT PRESCRIBING ERROR 7 0.0003
598 GAIT DISTURBANCE 56 0.0003
599 TREATMENT NONCOMPLIANCE 16 0.0003
600 THERAPY CESSATION 15 0.0003
601 LUNG NEOPLASM MALIGNANT 12 0.0003
602 MALAISE 128 0.0003
603 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
604 PERITONITIS 6 0.0003
605 INSOMNIA 77 0.0003
606 TENDERNESS 3 0.0003
607 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
608 SCRATCH 3 0.0003
609 SKIN REACTION 4 0.0003
610 FULL BLOOD COUNT ABNORMAL 3 0.0003
611 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
612 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
613 HAND FRACTURE 2 0.0003
614 THIRST 5 0.0003
615 RECTAL HAEMORRHAGE 12 0.0003
616 DISCOMFORT 17 0.0003
617 FEELING HOT 17 0.0003
618 SWELLING FACE 18 0.0003
619 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 56 0.0003
620 LEUKOCYTOSIS 5 0.0003
621 SKIN LACERATION 3 0.0003
622 HYPOKINESIA 4 0.0003
623 FAECES SOFT 2 0.0003
624 WOUND INFECTION 3 0.0003
625 HYPERTENSION 58 0.0003
626 MELAENA 6 0.0003
627 TOOTH FRACTURE 3 0.0003
628 HAEMATOCHEZIA 15 0.0003
629 BLOOD GLUCOSE ABNORMAL 5 0.0003
630 HAEMATOMA 7 0.0003
631 TACHYCARDIA 24 0.0003
632 TRANSAMINASES INCREASED 6 0.0003
633 DIPLOPIA 7 0.0003
634 HEPATOTOXICITY 6 0.0003
635 URTICARIA 45 0.0003
636 HEPATIC STEATOSIS 5 0.0003
637 MALNUTRITION 3 0.0003
638 OSTEOPOROSIS 11 0.0003
639 FISTULA 3 0.0003
640 HEPATIC ENZYME INCREASED 18 0.0003
641 IMPAIRED DRIVING ABILITY 3 0.0003
642 RENAL FAILURE 35 0.0003
643 DEATH 227 0.0003
644 SCAB 3 0.0003
645 INTERNAL HAEMORRHAGE 3 0.0003
646 HAEMODYNAMIC INSTABILITY 2 0.0003
647 ACIDOSIS 2 0.0003
648 PAIN IN EXTREMITY 77 0.0003
649 HIP ARTHROPLASTY 4 0.0003
650 BOWEL MOVEMENT IRREGULARITY 2 0.0003
651 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
652 LIPASE INCREASED 2 0.0003
653 LEUKOPENIA 13 0.0003
654 DELIRIUM 9 0.0003
655 HAEMOLYSIS 2 0.0003
656 RASH PRURITIC 14 0.0003
657 OEDEMA 14 0.0003
658 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
659 BLOOD CHOLESTEROL INCREASED 12 0.0003
660 HYPOALBUMINAEMIA 2 0.0003
661 COGNITIVE DISORDER 12 0.0003
662 INFUSION RELATED REACTION 17 0.0003
663 BRAIN FOG 4 0.0003
664 SLEEP DISORDER 18 0.0003
665 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
666 PARAESTHESIA 40 0.0003
667 DEVICE LEAKAGE 11 0.0003
668 FURUNCLE 2 0.0003
669 THERAPY INTERRUPTED 18 0.0003
670 MOOD SWINGS 8 0.0003
671 SCIATICA 4 0.0003
672 MUSCLE SPASMS 46 0.0003
673 CARDIAC FAILURE CONGESTIVE 20 0.0002
674 SKIN EXFOLIATION 21 0.0002
675 RESPIRATORY FAILURE 18 0.0002
676 DEPRESSED MOOD 13 0.0002
677 GASTROINTESTINAL DISORDER 22 0.0002
678 INTENTIONAL DOSE OMISSION 7 0.0002
679 INJURY ASSOCIATED WITH DEVICE 5 0.0002
680 ABNORMAL FAECES 2 0.0002
681 PLATELET COUNT DECREASED 26 0.0002
682 HYPERAESTHESIA 2 0.0002
683 ESCHERICHIA INFECTION 2 0.0002
684 HYPERCALCAEMIA 3 0.0002
685 TREMOR 40 0.0002
686 EMBOLISM 2 0.0002
687 LIVER FUNCTION TEST ABNORMAL 7 0.0002
688 EOSINOPHIL COUNT INCREASED 2 0.0002
689 PAIN 147 0.0002
690 DERMATITIS ALLERGIC 3 0.0002
691 TYPE 2 DIABETES MELLITUS 8 0.0002
692 ABDOMINAL PAIN LOWER 6 0.0002
693 PSYCHOTIC DISORDER 7 0.0002
694 GASTRIC CANCER 6 0.0002
695 OSTEOARTHRITIS 10 0.0002
696 CATARACT 14 0.0002
697 EATING DISORDER 5 0.0002
698 HEPATITIS 6 0.0002
699 DYSPNOEA 132 0.0002
700 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
701 NECK PAIN 13 0.0002
702 POOR QUALITY SLEEP 5 0.0002
703 RASH GENERALISED 6 0.0002
704 NEOPLASM PROGRESSION 8 0.0002
705 ORTHOSTATIC HYPOTENSION 4 0.0002
706 EPILEPSY 7 0.0002
707 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
708 CONTUSION 22 0.0002
709 DRUG ADMINISTRATION ERROR 7 0.0002
710 BRADYCARDIA 12 0.0002
711 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
712 RASH 98 0.0002
713 SWOLLEN TONGUE 7 0.0002
714 ADVERSE DRUG REACTION 20 0.0002
715 CHROMATURIA 5 0.0002
716 TOOTHACHE 4 0.0002
717 C-REACTIVE PROTEIN INCREASED 8 0.0002
718 PRODUCT AVAILABILITY ISSUE 5 0.0002
719 PNEUMONIA 71 0.0002
720 ACCIDENTAL OVERDOSE 8 0.0002
721 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
722 ABNORMAL DREAMS 6 0.0002
723 MENTAL STATUS CHANGES 6 0.0002
724 BLOOD CREATININE INCREASED 14 0.0002
725 BACTERIAL INFECTION 4 0.0002
726 CARPAL TUNNEL SYNDROME 3 0.0002
727 MIDDLE INSOMNIA 4 0.0002
728 BLOOD TEST ABNORMAL 3 0.0002
729 BLOOD SODIUM DECREASED 4 0.0002
730 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
731 LYMPHOPENIA 3 0.0002
732 SINUS TACHYCARDIA 3 0.0002
733 MUSCULOSKELETAL DISORDER 4 0.0002
734 NEOPLASM MALIGNANT 14 0.0002
735 RASH ERYTHEMATOUS 10 0.0002
736 PULMONARY FIBROSIS 4 0.0002
737 POST PROCEDURAL COMPLICATION 4 0.0002
738 DIZZINESS POSTURAL 2 0.0002
739 ASCITES 6 0.0002
740 MEMORY IMPAIRMENT 28 0.0002
741 LIVER INJURY 5 0.0002
742 ANGIOEDEMA 9 0.0002
743 ABDOMINAL DISCOMFORT 34 0.0002
744 SKIN HAEMORRHAGE 3 0.0002
745 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
746 PULMONARY MASS 3 0.0002
747 EPISTAXIS 15 0.0002
748 HYPOTONIA 2 0.0002
749 VOMITING 94 0.0002
750 SPINAL FRACTURE 4 0.0002
751 ANAPHYLACTIC REACTION 11 0.0002
752 HYPOAESTHESIA ORAL 3 0.0002
753 FULL BLOOD COUNT DECREASED 4 0.0002
754 UNEVALUABLE EVENT 15 0.0002
755 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
756 DEPRESSION 45 0.0002
757 PRODUCT USE IN UNAPPROVED INDICATION 49 0.0002
758 DRY THROAT 2 0.0002
759 FLUID RETENTION 10 0.0002
760 EAR DISCOMFORT 2 0.0002
761 THYROID DISORDER 3 0.0002
762 LYMPHOMA 3 0.0002
763 SOMNOLENCE 39 0.0002
764 PRURITUS 74 0.0002
765 ACUTE MYELOID LEUKAEMIA 3 0.0002
766 THERAPY PARTIAL RESPONDER 3 0.0002
767 HERPES ZOSTER 11 0.0002
768 CYANOSIS 3 0.0002
769 DYSPHAGIA 18 0.0002
770 ABDOMINAL PAIN UPPER 39 0.0002
771 PANCREATITIS 10 0.0002
772 ULCER 3 0.0002
773 ABSCESS 3 0.0002
774 SENSORY DISTURBANCE 3 0.0002
775 BLADDER CANCER 11 0.0002
776 HEREDITARY ANGIOEDEMA 2 0.0002
777 LIVER FUNCTION TEST INCREASED 4 0.0002
778 DYSARTHRIA 7 0.0002
779 JAUNDICE 5 0.0002
780 HYPOGLYCAEMIA 9 0.0002
781 BURNING SENSATION 13 0.0002
782 COLITIS 7 0.0002
783 FAECES DISCOLOURED 4 0.0002
784 NAUSEA 146 0.0002
785 BACK INJURY 2 0.0002
786 PRODUCT DOSE OMISSION 12 0.0002
787 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
788 MANIA 3 0.0002
789 SEIZURE 21 0.0002
790 THERAPEUTIC RESPONSE DECREASED 11 0.0002
791 RESPIRATORY DISTRESS 5 0.0002
792 TOOTH DISORDER 4 0.0002
793 BLOOD UREA INCREASED 3 0.0002
794 WOUND 5 0.0002
795 RASH PAPULAR 4 0.0002
796 INTESTINAL PERFORATION 2 0.0002
797 DIARRHOEA 115 0.0002
798 HYPONATRAEMIA 10 0.0002
799 ANGER 6 0.0002
800 HEMIPARESIS 3 0.0002
801 PAIN IN JAW 5 0.0002
802 FLATULENCE 10 0.0002
803 CIRCULATORY COLLAPSE 3 0.0002
804 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
805 FEELING ABNORMAL 42 0.0002
806 VISION BLURRED 24 0.0002
807 SKIN DISCOLOURATION 8 0.0002
808 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
809 PANCREATIC CARCINOMA 5 0.0002
810 NERVOUSNESS 9 0.0002
811 EYELID OEDEMA 2 0.0002
812 NEEDLE ISSUE 5 0.0002
813 LYMPHOCYTE COUNT DECREASED 3 0.0002
814 LABORATORY TEST ABNORMAL 5 0.0002
815 BLOOD IRON DECREASED 2 0.0002
816 FLUSHING 17 0.0002
817 HEPATIC CANCER 4 0.0002
818 CHEST DISCOMFORT 17 0.0002
819 JOINT SWELLING 20 0.0002
820 LOCALISED INFECTION 4 0.0002
821 ILL-DEFINED DISORDER 10 0.0002
822 INJECTION SITE HAEMORRHAGE 13 0.0002
823 EMOTIONAL DISORDER 5 0.0002
824 OFF LABEL USE 142 0.0002
825 DYSGEUSIA 12 0.0002
826 HALLUCINATION 12 0.0002
827 BLOOD GLUCOSE INCREASED 30 0.0002
828 INTESTINAL OBSTRUCTION 6 0.0002
829 INFECTION 23 0.0002
830 METABOLIC ACIDOSIS 5 0.0002
831 LOWER LIMB FRACTURE 3 0.0002
832 ACUTE RESPIRATORY FAILURE 3 0.0002
833 DRUG RESISTANCE 4 0.0002
834 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
835 CHOKING 3 0.0002
836 ORAL HERPES 3 0.0002
837 PRODUCT DOSE OMISSION ISSUE 45 0.0002
838 DEAFNESS 4 0.0002
839 KIDNEY INFECTION 3 0.0002
840 SPEECH DISORDER 8 0.0002
841 IMMUNE SYSTEM DISORDER 2 0.0002
842 DISABILITY 3 0.0002
843 HEART RATE INCREASED 15 0.0002
844 LIP SWELLING 5 0.0001
845 CARDIAC DISORDER 14 0.0001
846 JOINT RANGE OF MOTION DECREASED 2 0.0001
847 DRY MOUTH 12 0.0001
848 HEADACHE 92 0.0001
849 CONDITION AGGRAVATED 44 0.0001
850 ROAD TRAFFIC ACCIDENT 6 0.0001
851 HAEMOPTYSIS 4 0.0001
852 HOSPITALISATION 22 0.0001
853 HYPERSENSITIVITY 26 0.0001
854 IRRITABLE BOWEL SYNDROME 3 0.0001
855 CONVULSION 8 0.0001
856 AGGRESSION 7 0.0001
857 MYELOSUPPRESSION 5 0.0001
858 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
859 GASTROENTERITIS 2 0.0001
860 RENAL INJURY 4 0.0001
861 HAEMORRHAGE INTRACRANIAL 2 0.0001
862 RESPIRATORY DISORDER 4 0.0001
863 BONE LOSS 2 0.0001
864 IRRITABILITY 8 0.0001
865 CORONARY ARTERY DISEASE 4 0.0001
866 BLOOD COUNT ABNORMAL 2 0.0001
867 NEPHROLITHIASIS 6 0.0001
868 VISUAL IMPAIRMENT 16 0.0001
869 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
870 EJECTION FRACTION DECREASED 2 0.0001
871 BASAL CELL CARCINOMA 2 0.0001
872 HEAD INJURY 4 0.0001
873 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
874 ABNORMAL BEHAVIOUR 5 0.0001
875 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
876 COVID-19 22 0.0001
877 INJECTION SITE BRUISING 10 0.0001
878 LACTIC ACIDOSIS 4 0.0001
879 DEEP VEIN THROMBOSIS 8 0.0001
880 BLINDNESS 5 0.0001
881 AGITATION 9 0.0001
882 LUNG DISORDER 6 0.0001
883 ENCEPHALOPATHY 3 0.0001
884 EYE DISORDER 4 0.0001
885 DRY SKIN 16 0.0001
886 PALPITATIONS 14 0.0001
887 SURGERY 7 0.0001
888 ADVERSE EVENT 11 0.0001
889 CARDIOVASCULAR DISORDER 3 0.0001
890 NIGHTMARE 4 0.0001
891 STOMATITIS 7 0.0001
892 RESPIRATORY TRACT INFECTION 3 0.0001
893 ALOPECIA 22 0.0001
894 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
895 MOOD ALTERED 3 0.0001
896 END STAGE RENAL DISEASE 2 0.0001
897 SKIN LESION 3 0.0001
898 DRUG DOSE OMISSION 18 0.0001
899 RESPIRATORY ARREST 3 0.0001
900 ARTHROPATHY 6 0.0001
901 INFLUENZA 12 0.0001
902 RENAL DISORDER 5 0.0001
903 BLISTER 6 0.0001
904 HEPATIC CIRRHOSIS 2 0.0001
905 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
906 DRUG PRESCRIBING ERROR 2 0.0001
907 GLAUCOMA 2 0.0001
908 MUSCULOSKELETAL STIFFNESS 9 0.0001
909 DYSPHONIA 6 0.0001
910 WHEEZING 6 0.0001
911 SUICIDE ATTEMPT 6 0.0001
912 DYSKINESIA 4 0.0001
913 SUICIDAL IDEATION 9 0.0001
914 NERVOUS SYSTEM DISORDER 3 0.0001
915 CARDIO-RESPIRATORY ARREST 4 0.0001
916 ECZEMA 5 0.0001
917 WITHDRAWAL SYNDROME 4 0.0001
918 DRUG INTOLERANCE 9 0.0001
919 HYPOACUSIS 4 0.0001
920 RHINORRHOEA 6 0.0001
921 MENTAL DISORDER 4 0.0001
922 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
923 CHOLELITHIASIS 3 0.0001
924 DYSPEPSIA 9 0.0001
925 VISUAL ACUITY REDUCED 3 0.0001
926 MEDICATION ERROR 5 0.0001
927 SKIN DISORDER 3 0.0001
928 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
929 ARTHRITIS 7 0.0001
930 THERAPY NON-RESPONDER 4 0.0001
931 OXYGEN SATURATION DECREASED 5 0.0001
932 HEART RATE IRREGULAR 2 0.0001
933 NO ADVERSE EVENT 16 0.0001
934 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
935 NASOPHARYNGITIS 16 0.0001
936 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
937 HAEMORRHAGE 9 0.0001
938 COUGH 24 0.0001
939 HYPOXIA 3 0.0001
940 NASAL CONGESTION 5 0.0001
941 TREATMENT FAILURE 7 0.0001
942 RENAL CANCER 4 0.0001
943 OVERDOSE 18 0.0001
944 BLOOD PRESSURE FLUCTUATION 2 0.0001
945 PANIC ATTACK 3 0.0001
946 RESTLESSNESS 3 0.0001
947 EYE SWELLING 3 0.0001
948 INTENTIONAL PRODUCT MISUSE 7 0.0001
949 ANXIETY 22 0.0001
950 EXPOSURE VIA SKIN CONTACT 2 0.0001
951 JOINT STIFFNESS 2 0.0001
952 ANHEDONIA 2 0.0001
953 THROMBOSIS 6 0.0001
954 FEAR 2 0.0001
955 DISTURBANCE IN ATTENTION 4 0.0001
956 DIVERTICULITIS 2 0.0001
957 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
958 DRUG INEFFECTIVE 93 0.0001
959 SINUSITIS 7 0.0001
960 PULMONARY OEDEMA 3 0.0001
961 THROAT IRRITATION 3 0.0001
962 LACRIMATION INCREASED 2 0.0001
963 SKIN IRRITATION 3 0.0001
964 TINNITUS 3 0.0001
965 BONE DENSITY DECREASED 2 0.0001
966 OCULAR HYPERAEMIA 3 0.0001
967 COMA 3 0.0001
968 PRODUCTIVE COUGH 3 0.0001
969 GASTRIC DISORDER 2 0.0001
970 ILLNESS 6 0.0001
971 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
972 DEVICE MALFUNCTION 4 0.0001
973 DRUG EFFECT DECREASED 3 0.0001
974 OROPHARYNGEAL PAIN 5 0.0001
975 CHRONIC KIDNEY DISEASE 4 0.0001
976 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
977 DEVICE ISSUE 4 0.0000
978 BLOOD GLUCOSE DECREASED 2 0.0000
979 BRONCHITIS 3 0.0000
980 DRY EYE 2 0.0000
981 ACNE 3 0.0000
982 PRODUCT QUALITY ISSUE 5 0.0000
983 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
984 EYE PAIN 2 0.0000
985 ASTHMA 4 0.0000
986 EMOTIONAL DISTRESS 4 0.0000
987 TOXICITY TO VARIOUS AGENTS 4 0.0000
988 PSORIASIS 3 0.0000